Biotechnology News

February 7, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to present the newest set of photographs showing evidence that the cancer cells...

February 7, 2012

NAARDEN, The Netherlands--(BUSINESS WIRE)--BAC BV and Life Technologies launch high speed affinity HPLC columns for real-time pharmaceutical process monitoring

February 7, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Presentation of results for fourth quarter 2011 will take place 09:30 (Norwegian time), Tuesday 14 February at Felix Conference Centre, Bryggetorget 3, Aker brygge in Oslo. The presentation will be...

February 7, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (publ) (STO:VITR): Fourth quarter -- Sales increased by 19 percent in local currency. Sales were the highest ever for a single quarter and amounted to SEK 95 (81) million,...

February 6, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) will release its fourth quarter and full year 2011 financial results on Wednesday, February 8, 2012, after the markets close. The announcement will be followed by a live...

February 6, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Company management will present at the Leerink Swann Global Healthcare Conference on Wednesday, February 15, 2012 at 1:30 PM Eastern Time and the Citi 2012...

February 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) today announced the completion of the sale of 1,050,000 additional shares of its common stock aggregate net proceeds from the offering were approximately $32.9 million.

February 6, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the 14th Annual Bio CEO and Investor Conference in New York on Monday, February 13, 2012 at 9:30 a.m. ET and the Leerink Swann Global...

February 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus to present at Annual BIO CEO & Investor Conference

February 6, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Amyris to provide update call with investors on February 9, 2012 and to report 2011 Fourth Quarter and Year End Financial Results on February 27. Also, will participate in investor conferences.

February 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Synchroneuron Completes $6 Million Series A Financing to Fund Development of a Novel Treatment for Movement Disorders

February 6, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012, at 2:30 p.m. EST (7:30 p.m. GMT) from the...

February 6, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to Highlight Product Development Activities at ORS and AAOS Meetings and Announces Results of its Augment® Rotator Cuff Graft Clinical Trial

February 6, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASi Inc. has opened its new Discovery Center designed to provide pharmaceutical and biotech companies with the information they need to evaluate new compounds in the earliest stages of development

February 6, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar VP Leon Dzivinsky to present on Conducting Clinical Research in the Emerging Market of Russia Under the New Regulations at Outsourcing in Clinical Trials West Coast conference Feb. 15-16th

February 6, 2012

BOSTON--(BUSINESS WIRE)--Scientia Advisors announces that Meghan Needham has joined the company as Director of Marketing. She’ll be helping to drive development and execution of marketing and branding initiatives.

February 6, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Science's presentation time at the UBS Healthcare Services Conference is 4 p.m. ET and not 3 p.m. ET, as previously announced.

February 6, 2012

NEW YORK--(BUSINESS WIRE)--Each year, over 700,000 people in the United States suffer a stroke. For most, medical science can do very little. Some will die; a number will suffer debilitating aftereffects. Now, preliminary results of a Phase 2...

February 6, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is hosting a series of events at the 1st Annual Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition to...

February 6, 2012

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics announced that Dr. Giora Weisz will present his personal experience using the CorPath 200 System at CRT2012 on February 7.

February 6, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--An article was published in HemOnc Today, reporting on the promise of Biovest’s BiovaxID® personalized lymphoma cancer vaccine.

February 6, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte released a novel software algorithm that enables a greater range of fluid types—cell lysates, proteins, and varying reagent concentrations—to be automatically transferred with acoustic energy.

February 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (Nasdaq: IDRA) today announced that Sudhir Agrawal, D.Phil., Chairman and Chief Executive Officer, is scheduled to present at the 14th Annual BIO CEO & Investor Conference on February...

February 6, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today...

February 6, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR TherapeuticTM, today announced that: J. Donald deBethizy, Ph.D., Targacept’s President and Chief Financial...

February 6, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which,...

February 6, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus' William “Obi” Greenman, president and chief executive officer, to present at 14th Annual BIO CEO & Investor Conference in New York at 10:30 AM ET on Monday, February 13, 2012.

February 6, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David...

February 6, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its partner GlaxoSmithKline (GSK) has voluntarily paused enrollment in its current clinical trials of GSK2251052 (GSK ‘052) due to a recently identified...

February 6, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (NASDAQ: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, and BD Diagnostics, a segment of BD (...

February 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta (NASDAQ: SNTA) today announced that the Company will be presenting at the 2012 Biotechnology Industry Organization CEO & Investor Conference on Monday, February 13 at 9:30 am ET.

February 6, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today announced results for its fiscal 2012 first quarter.

February 6, 2012

LEXINGTON, Mass. and SALZBURG, Austria--(BUSINESS WIRE)--New HeatWave™ TS chips provide precision and speed in automated targeted sequencing and validation workflows using RainDance’s new ThunderStorm™ System

February 6, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it will be participating in the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012, at 3:00 p.m. ET and in the 2012 Citi...

February 6, 2012

SAN DIEGO--(BUSINESS WIRE)--Four new cellular assay kits to help identify and characterize possible drug candidates targeting epigenetic enzymes related to key disease states

February 6, 2012

IRVINE, Calif.--(BUSINESS WIRE)--BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry....

February 6, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen announced today that Dr. Anat-Cohen Dayag, Compugen's President and CEO, is scheduled to present at the upcoming BIO CEO & Investor Conference 2012

February 6, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-...

February 6, 2012

DUBLIN, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief...

February 6, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--ETView Medical, Ltd. Announced Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the Viva™ EB Line of Innovative Endobronchial Blockers

February 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences announces allowance for fifth and sixth patent applications for genome engineering

February 6, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Negotiates Funding Terms With n3D

February 6, 2012

LONDON--(BUSINESS WIRE)--Citi today announced that its Global Transaction Services business, acting through Citibank N.A., has been appointed by Elan Corporation, plc (“Elan”), a leading biotechnology company headquartered in Ireland, as the...

February 6, 2012

TAINAN, Taiwan--(BUSINESS WIRE)--NCKU’s research on heat-tolerant cauliflower seedlings benefits world food supply

February 6, 2012

MELBOURNE, Australia & BAAR, Switzerland--(BUSINESS WIRE)--Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class drug...

February 6, 2012

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--Drug discovery and development company e-Therapeutics plc (AIM: ETX) announces that Dr Rajesh Chopra has joined the Company’s Board as a Non-Executive Director. A clinician and scientist by...

February 3, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics announced today that it will host a live webcast of its Annual Meeting of Shareholders on Monday, February 6, at 4:00 p.m. CT.

February 3, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will be hosting a live webcast of its first quarter 2012 conference...